1. Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983 Dec; 58(12):802–4 .
2. Nölting S, Ullrich M, Pietzsch J, Ziegler CG, Eisenhofer G, Grossman A, et al. Current Management of Pheochromocytoma/ Para ganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine. Cancers. 2019 Oct 8; 11(10).
3. Kliewer KE, Wen DR, Cancilla PA, Cochran AJ. Paragangliomas: assessment of progno-sis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol. 1989 Jan; 20(1):29–39 .
4. Eisenhofer G, Klink B, Richter S, Lenders JW, Robledo M. Metabologenomics of Phaeo-chromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing. Clin Biochem Rev. 2017 Apr; 38(2):69–100 .
5. Timmers HJLM, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst. 2012 May 2; 104(9):700–8 .
6. Han S, Suh CH, Woo S, Kim YJ, Lee JJ. Performance of 68Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis. J Nucl Med Off Publ Soc Nucl Med. 2019; 60(3):369–76 .
7. Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JWM, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016 May; 174(5):G1–10 .
8. Lu L, Yang Z, Zhang G, An B, Lin Y, Zheng X. Challenges in the surgical treatment of undiagnosed functional paragangliomas: A case report. Medicine (Baltimore). 2018 Sep; 97(38):e12478 .
9. Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR, et al. Pheochro-mocytoma: an imaging chameleon. Radio Rev Publ Radiol Soc N Am Inc. 2004 Oct; 24 Suppl 1:S87-99 .
10. Opocher G, Schiavi F. Genetics of pheochromocytomas and paragang-liomas. Best Pract Res Clin Endocrinol Metab. 2010 Dec; 24(6):943–56 .
11. Wen J, Li H-Z, Ji ZG, Mao QZ, Shi BB, Yan WG.
A decade of clinical experience with extra-adrenal paragangliomas of retroperito-neum: Report of 67 cases and a literature review. Urol Ann. 2010 Jan; 2(1):12–6 .
12. Magliulo G, Zardo F, Varacalli S, D’Amico R. Multiple paragangliomas of the head and neck. An Otorrinolaringol Ibero-Am. 2003; 30(1):31–8 .
13. Aygun N, Uludag M. Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings. Sisli Etfal Hassan Tip Bul. 2020; 54(2):159–68 .
14. Ramage JK, Davies AHG, Ardill J, Bax N, Caplin M, Grossman A, et al. Guidelines for the management of gastroentero-pancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005 Jun; 54 Suppl 4:iv1-16.